1. Home
  2. ALT vs API Comparison

ALT vs API Comparison

Compare ALT & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • API
  • Stock Information
  • Founded
  • ALT 1997
  • API 2013
  • Country
  • ALT United States
  • API United States
  • Employees
  • ALT N/A
  • API N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • API Computer Software: Prepackaged Software
  • Sector
  • ALT Health Care
  • API Technology
  • Exchange
  • ALT Nasdaq
  • API Nasdaq
  • Market Cap
  • ALT 397.4M
  • API 346.0M
  • IPO Year
  • ALT N/A
  • API 2020
  • Fundamental
  • Price
  • ALT $4.16
  • API $4.18
  • Analyst Decision
  • ALT Strong Buy
  • API Strong Buy
  • Analyst Count
  • ALT 6
  • API 1
  • Target Price
  • ALT $18.20
  • API $6.00
  • AVG Volume (30 Days)
  • ALT 11.4M
  • API 408.6K
  • Earning Date
  • ALT 08-07-2025
  • API 08-18-2025
  • Dividend Yield
  • ALT N/A
  • API N/A
  • EPS Growth
  • ALT N/A
  • API N/A
  • EPS
  • ALT N/A
  • API N/A
  • Revenue
  • ALT $20,000.00
  • API $133,504,000.00
  • Revenue This Year
  • ALT N/A
  • API $7.10
  • Revenue Next Year
  • ALT $1,557,547.90
  • API $10.91
  • P/E Ratio
  • ALT N/A
  • API N/A
  • Revenue Growth
  • ALT N/A
  • API N/A
  • 52 Week Low
  • ALT $2.90
  • API $1.65
  • 52 Week High
  • ALT $11.16
  • API $6.99
  • Technical
  • Relative Strength Index (RSI)
  • ALT 40.54
  • API 61.82
  • Support Level
  • ALT $4.07
  • API $3.60
  • Resistance Level
  • ALT $4.79
  • API $4.31
  • Average True Range (ATR)
  • ALT 0.45
  • API 0.18
  • MACD
  • ALT -0.10
  • API 0.02
  • Stochastic Oscillator
  • ALT 28.16
  • API 79.83

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About API Agora Inc.

Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.

Share on Social Networks: